All News

Intratumoral SD-101 and Keytruda proved to be well-tolerated for patients with early stage melanoma, according to the results of a recent study.

An expert sat down with CURE to discuss standard therapies for localized prostate cancer.

Midostaurin was granted a priority review for a new drug application by the FDA to treat a subset of patients with acute myeloid leukemia.

Breast cancer and melanoma survivor gets out of her thoughts by getting outdoors and re-prioritizing her life.

Cancer jargon is sometimes lost in translation.

According to results from a recent study, Keytruda had longer overall survival (OS) when compared to chemotherapy for patients with bladder cancer.

The NCCN updated their guidelines on treatment for myeloproliferative neoplasms (MPNs), outlining diagnosis, treatment and care strategies.

Leena Gandhi discusses current and emerging treatment strategies for patients with ALK-rearranged lung cancer.

One woman's experience with her oncologist when the time came around for a mammogram.

It can be hard to name our fears, especially when we are worried that others don't share them or that they will make us feel like a part of our community. In sharing, we can name stressors, activate healing from those stressors and give our bodies a chance to cope with all that has happened to us.

Tumor-treating fields are having a huge impact on the treatment and outcomes of patients with glioblastoma multiforme (GBM).

Stivarga is being considered by the FDA for approval for second-line liver cancer treatment, renewing hope in the field.

Kimberly Blackwell, M.D., discusses advancements in the field of HER2+ breast cancer.

A cancer diagnosis comes served up with a slew of side effects. While many can be anticipated and managed, some cannot. They can crop up unexpectedly and take up residence indefinitely.

When receiving a cancer diagnosis, it means so much to have others be there for you.

Robotic surgery is a promising option in the field of prostate cancer, leading to better outcomes and shorter hospital stays.

Optimizing the use of neoadjuvant chemotherapy could improve outcomes for patients with ovarian cancer.

Checkpoint inhibitors such as Opdivo and Yervoy are showing promise in treating MDS and AML.

Many patients with melanoma develop a resistance to targeted therapy, but new options to prevent resistance are being explored.

Respect the right of a patient with cancer to decide against treatment or to reach a point where fighting the disease is no longer worth the suffering.

Opdivo was approved for patients with metastatic or recurrent squamous cell carcinoma of the head and neck.

Fewer than half the women with advanced cervical cancer are receiving standard of care.

Rimas Lukas discusses the evolving field of glioblastoma multiforme (GBM) treatment.

Clutter clearing speaker/author turned two-time cancer survivor shares her holiday tips.

Holidays can be challenging, but here are a few helpful tips to surviving well.

Biomarkers have value in the diagnosis and monitoring of bladder cancer, but their use is still being perfected.

According to a recent trial, an immunotherapy combination was shown to be effective in high-risk melanoma. But because of the high toxicity profile, more research is needed.

In a word, everything.

Srdan Verstovsek, M.D., Ph.D. talks to CURE about recent advances in treating MPNs.